The CTSA Program is designed to develop innovative solutions that will improve the efficiency, quality and impact of the process for turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public. Learn more.
-
Research
-
-
Funding & Notices
-
-
News & Media
-
About Translation
-
-
About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- NCATS Chemical Genomics Center (NCGC)
- NIH Common Fund Programs
- Pfizer's Centers for Therapeutic Innovation (CTI) for NIH Researchers
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Trans-NIH RNAi Facility (TNRF)
- Therapeutics for Rare and Neglected Diseases (TRND)
-